To access this element change to forms mode OFF
Grant Award View - GA268499
Immune responses to SARS-CoV-2 variants across age groups and vulnerable...
GA ID:
GA268499
Agency:
Department of Health and Aged Care
Approval Date:
19-Jun-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
19-Jun-2022 to 31-May-2025
Value (AUD):
$3,001,424.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
Immune responses to SARS-CoV-2 variants across age groups and vulnerable populations
Purpose:
Understanding immune responses underpinning protection against emerging SARS-CoV-2 variants of concern is urgently needed. Our MRFF encompasses Australia’s most advanced COVID-19 immunology program which will define protective and long-lasting immunity against emerging variants across age groups and vulnerable populations. Our in-depth immune studies in wide ranging cohorts will inform potential therapy and vaccine regimens for at-risk groups to limit disease spread and protect high-risk groups.
GO ID:
GO Title:
MRFF – CRR – 2021 COVID-19 Treatment Access and Public Health Activities Grant Opportunity
Internal Reference ID:
2022/MRF2016062
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, NT, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES